Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer	Locally Advanced Rectal Cancer	Recruiting	Phase 2	2024-01-10		NCT05245474

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BeiGene	47
Beijing Chao Yang Hospital	88
Beijing Friendship Hospital	120
Beijing Hospital	51
Peking Union Medical College Hospital	417
Peking University Cancer Hospital & Institute	189
Peking University First Hospital	225
Peking University People's Hospital	269
Xuanwu Hospital, Beijing	232

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Cancer Hospital	Beijing	China	55
Beijing Chaoyang Hospital, Capital Medical University	Beijing	China	5
Beijing Friendship Hospital, Capital Medical University	Beijing	China	64
Beijing Hospital	Beijing	China	15
Peking Union Medical College Hospital	Beijing	China	48
Peking University First Hospital	Beijing	China	41
Peking University People's Hospital	Beijing	China	44
Xuanwu Hospital, Capital Medical University	Beijing	China	8